Litcius/Paper detail

Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies

Katharigatta N. Venugopala, Sandeep Chandrashekharappa, Pran Kishore Deb, Nizar A. Al‐Shar’i, Melendhran Pillay, Priya Tiwari, Deepak Chopra, Pobitra Borah, Rasoul Tamhaev, Lionel Mourey, Christian Lherbet, Bandar E. Al‐Dhubiab, Christophe Tratrat, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Raghu Prasad Mailavaram, Rashmi Venugopala, Viresh Mohanlall, Mohamed A. Morsy

2024International Journal of Biological Macromolecules14 citationsDOIOpen Access PDF

Topics & Concepts

INHAIndolizineChemistryStereochemistryIn silicoIn vitroEnzymeDocking (animal)Mycobacterium tuberculosisBiochemistryTuberculosisMedicineGenePathologyNursingSynthesis and Reactivity of HeterocyclesCancer therapeutics and mechanismsTuberculosis Research and Epidemiology
Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies | Litcius